Insights from 2024 ESGO Annual Meeting
Risk Stratification of Endometrial Cancer & Selinexor Maintenance for Patients With TP53wt Advanced or Recurrent Disease
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Jalid Sehouli
By
Insights from 2024 ESGO Annual Meeting
FEATURING
Jalid Sehouli
Comments 0
Login to view comments.
Click here to Login